Response to: “A somatization comorbidity phenotype impacts response to therapy in rheumatoid arthritis: post hoc results from the certolizumab pegol phase 4 PREDICT trial”

Detalles Bibliográficos
Autores principales: Madison, Annelise, Andersen, Barbara L., Ajam, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381628/
https://www.ncbi.nlm.nih.gov/pubmed/30786929
http://dx.doi.org/10.1186/s13075-019-1848-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381628/
https://www.ncbi.nlm.nih.gov/pubmed/30786929
http://dx.doi.org/10.1186/s13075-019-1848-4

Ejemplares similares